Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
9 studies found for:    aphasia and university of pennsylvania
Show Display Options
Rank Status Study
1 Active, not recruiting Transcranial Magnetic Stimulation to Improve Speech in Aphasia
Conditions: Aphasia;   Cerebrovascular Stroke
Intervention: Device: Transcranial Magnetic Stimulation, Repetitive
2 Recruiting Tau Imaging in Young Onset Dementia
Conditions: Alzheimer's Disease, Early Onset;   Logopenic Progressive Aphasia;   Posterior Cortical Atrophy (PCA)
Intervention: Drug: [18F]-T807 imaging tracer
3 Completed Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.
Conditions: Memory Disorders;   Alzheimer Disease;   Dementia;   Cognitive Impairment;   Frontotemporal Dementia
Intervention: Device: COGNISION™ System
4 Completed
Has Results
Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia
Conditions: Frontal Lobe Dementia;   Frontotemporal Lobe Dementia;   Semantic Dementia
Interventions: Drug: memantine;   Drug: Placebo pill
5 Recruiting Living With Frontotemporal Dementia
Condition: Adaptation
Intervention:
6 Enrolling by invitation Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Conditions: Alzheimer's Disease;   Behavioral Variant Frontotemporal Dementia
Intervention: Drug: TRx0237
7 Recruiting Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Condition: Behavioral Variant Frontotemporal Dementia (bvFTD)
Interventions: Drug: TRx0237;   Drug: Placebo
8 Recruiting Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation
Condition: Granulin Mutation
Interventions: Drug: FRM-0334;   Drug: Placebo
9 Recruiting Dosage and Predictors of Naming Treatment Response in Aphasia
Conditions: Aphasia;   Stroke
Intervention: Behavioral: Naming therapy

Indicates status has not been verified in more than two years